Novel opportunities for the exploitation of host-microbiome interactions in the intestine

Current Opinion in Biotechnology

Volumn 32, Issue , 2015, Pages 28-34

  Claes, Ingmar JJ ^a,b   Vargas García, Cynthia E ^a,b   Lebeer, Sarah ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTICS;

INTERVENTION STRATEGY; MICROBIOME; MICROBIOTAS; MOLECULAR LEVELS; PREBIOTICS; PROBIOTIC STRAIN;

PHYSIOLOGICAL MODELS;

NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PATTERN RECOGNITION RECEPTOR; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; AMIDASE; CHOLOYLGLYCINE HYDROLASE; PREBIOTIC AGENT;

AKKERMANSIA MUCINIPHILA; BIFIDOBACTERIUM; CLOSTRIDIUM DIFFICILE INFECTION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DYSBIOSIS; FAECALIBACTERIUM PRAUSNITZII; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; FERMENTED PRODUCT; GENE SEQUENCE; GENETIC PROCEDURES; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE FLORA; LACTOBACILLUS; MICROBE ASSOCIATED MOLECULAR PATTERN; MICROBIOLOGICAL PARAMETERS; MICROBIOME; MOLECULAR DYNAMICS; MOLECULAR GENETICS; MOLECULAR RECOGNITION; NEXT GENERATION SEQUENCING; NONHUMAN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; REVIEW; SIGNAL TRANSDUCTION; TRANSPLANTATION; VERRUCOMICROBIUM; ANIMAL; FECES; INTESTINE; METABOLIC SYNDROME X; METABOLISM; MICROBIOLOGY; MICROFLORA;

AMIDOHYDROLASES; ANIMALS; FECES; HUMANS; INTESTINES; METABOLIC SYNDROME X; MICROBIOTA; PREBIOTICS; PROBIOTICS;

EID: 84910680899     PISSN: 09581669     EISSN: 18790429     Source Type: Journal    
DOI: 10.1016/j.copbio.2014.10.008     Document Type: Review

References (61)

1. Kim B.S., Jeon Y.S., Chun J. Current status and future promise of the human microbiome. Pediatr Gastroenterol Hepatol Nutr 2013, 16:71-79.
2. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., Fernandes G.R., Tap J., Bruls T., Batto J.M., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
3. Siezen R.J., Kleerebezem M. The human gut microbiome: are we our enterotypes?. Microb Biotechnol 2011, 4:550-553.
4. Wu G.D., Chen J., Hoffmann C., Bittinger K., Chen Y.Y., Keilbaugh S.A., Bewtra M., Knights D., Walters W.A., Knight R., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334:105-108.
5. De Filippo C., Cavalieri D., Di Paola M., Ramazzotti M., Poullet J.B., Massart S., Collini S., Pieraccini G., Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010, 107:14691-14696.
6. Ou J., Carbonero F., Zoetendal E.G., DeLany J.P., Wang M., Newton K., Gaskins H.R., O'Keefe S.J. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr 2013, 98:111-120.
7. Schnorr S.L., Candela M., Rampelli S., Centanni M., Consolandi C., Basaglia G., Turroni S., Biagi E., Peano C., Severgnini M., et al. Gut microbiome of the Hadza hunter-gatherers. Nat Commun 2014, 5:3654.
8. Yatsunenko T., Rey F.E., Manary M.J., Trehan I., Dominguez-Bello M.G., Contreras M., Magris M., Hidalgo G., Baldassano R.N., Anokhin A.P., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486:222-227.
9. Li J., Jia H., Cai X., Zhong H., Feng Q., Sunagawa S., Arumugam M., Kultima J.R., Prifti E., Nielsen T., et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 2014, 32:834-841.
10. David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E., Ling A.V., Devlin A.S., Varma Y., Fischbach M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505:559-563.
11. Ho N., Prasad V. Probiotics, prebiotics, synbiotics and naturally fermented foods: why more may be more. Ann Gastroenterol 2013, 26:277-278.
12. Frost, Sullivan Strategic Analysis of the European Food and Beverage Probiotics Markets 2007, B956-B988.
13. Petrof E.O., Khoruts A. From stool transplants to next-generation microbiota therapeutics. Gastroenterology 2014, 146:1573-1582.
14. Vrieze A., Van Nood E., Holleman F., Salojarvi J., Kootte R.S., Bartelsman J.F., Dallinga-Thie G.M., Ackermans M.T., Serlie M.J., Oozeer R., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012, 143:913-916. e917.
15. Petrof E.O., Gloor G.B., Vanner S.J., Weese S.J., Carter D., Daigneault M.C., Brown E.M., Schroeter K., Allen-Vercoe E. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome 2013, 1:3.
16. Smith M.B., Kelly C., Alm E.J. Policy: how to regulate faecal transplants. Nature 2014, 506:290-291.
17. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermudez-Humaran L.G., Gratadoux J.J., Blugeon S., Bridonneau C., Furet J.P., Corthier G., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008, 105:16731-16736.
18. Miquel S., Martin R., Rossi O., Bermudez-Humaran L.G., Chatel J.M., Sokol H., Thomas M., Wells J.M., Langella P. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol 2013, 16:255-261.
19. Candela M., Rampelli S., Turroni S., Severgnini M., Consolandi C., De Bellis G., Masetti R., Ricci G., Pession A., Brigidi P. Unbalance of intestinal microbiota in atopic children. BMC Microbiol 2012, 12:95.
20. Swidsinski A., Dorffel Y., Loening-Baucke V., Theissig F., Ruckert J.C., Ismail M., Rau W.A., Gaschler D., Weizenegger M., Kuhn S., et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 2011, 60:34-40.
21. Derrien M., Vaughan E.E., Plugge C.M., de Vos W.M. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 2004, 54:1469-1476.
22. Everard A., Belzer C., Geurts L., Ouwerkerk J.P., Druart C., Bindels L.B., Guiot Y., Derrien M., Muccioli G.G., Delzenne N.M., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 2013, 110:9066-9071.
23. Qin J., Li Y., Cai Z., Li S., Zhu J., Zhang F., Liang S., Zhang W., Guan Y., Shen D., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490:55-60.
24. Kang C.S., Ban M., Choi E.J., Moon H.G., Jeon J.S., Kim D.K., Park S.K., Jeon S.G., Roh T.Y., Myung S.J., et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS ONE 2013, 8:e76520.
25. Al-Hassi H.O., Mann E.R., Sanchez B., English N.R., Peake S.T., Landy J., Man R., Urdaci M., Hart A.L., Fernandez-Salazar L., et al. Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp. Mol Nutr Food Res 2014, 58:1132-1143.
26. Yan F., Liu L., Dempsey P.J., Tsai Y.H., Raines E.W., Wilson C.L., Cao H., Cao Z., Liu L., Polk D.B. A Lactobacillus rhamnosus GG-derived soluble protein, p40, stimulates ligand release from intestinal epithelial cells to transactivate epidermal growth factor receptor. J Biol Chem 2013, 288:30742-30751.
27. Flint H.J., Scott K.P., Duncan S.H., Louis P., Forano E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 2012, 3:289-306.
28. Hamer H.M., Jonkers D.M., Vanhoutvin S.A., Troost F.J., Rijkers G., de Bruine A., Bast A., Venema K., Brummer R.J. Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. Clin Nutr 2010, 29:738-744.
29. Lebeer S., Vanderleyden J., De Keersmaecker S.C. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 2010, 8:171-184.
30. de Kivit S., Tobin M.C., Forsyth C.B., Keshavarzian A., Landay A.L. Regulation of intestinal immune responses through TLR activation: implications for pro- and prebiotics. Front Immunol 2014, 5:60.
31. Strober W., Murray P.J., Kitani A., Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 2006, 6:9-20.
32. Li J., Lee D.S., Madrenas J. Evolving bacterial envelopes and plasticity of TLR2-dependent responses: basic research and translational opportunities. Front Immunol 2013, 4:347.
33. Hoving J.C., Wilson G.J., Brown G.D. Signalling C-type lectin receptors, microbial recognition and immunity. Cell Microbiol 2014, 16:185-194.
34. Cambi A., Figdor C.G. Levels of complexity in pathogen recognition by C-type lectins. Curr Opin Immunol 2005, 17:345-351.
35. Comstock L.E. Importance of glycans to the host-bacteroides mutualism in the mammalian intestine. Cell Host Microbe 2009, 5:522-526.
36. Konstantinov S.R., Smidt H., de Vos W.M., Bruijns S.C., Singh S.K., Valence F., Molle D., Lortal S., Altermann E., Klaenhammer T.R., et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A 2008, 105:19474-19479.
37. Tytgat H.L., Lebeer S. The sweet tooth of bacteria: common themes in bacterial glycoconjugates. Microbiol Mol Biol Rev 2014, 78. 10.1128/MMBR.00007-00014.
38. Stowell S.R., Arthur C.M., McBride R., Berger O., Razi N., Heimburg-Molinaro J., Rodrigues L.C., Gourdine J.P., Noll A.J., von Gunten S., et al. Microbial glycan microarrays define key features of host-microbial interactions. Nat Chem Biol 2014, 10:470-476.
39. Sanchez-Rodriguez A., Tytgat H.L., Winderickx J., Vanderleyden J., Lebeer S., Marchal K. A network-based approach to identify substrate classes of bacterial glycosyltransferases. BMC Genomics 2014, 15:349.
40. Cantarel B.L., Lombard V., Henrissat B. Complex carbohydrate utilization by the healthy human microbiome. PLoS ONE 2012, 7:e28742.
41. Wang Y., Devkota S., Musch M.W., Jabri B., Nagler C., Antonopoulos D.A., Chervonsky A., Chang E.B. Regional mucosa-associated microbiota determine physiological expression of TLR2 and TLR4 in murine colon. PLoS ONE 2010, 5:e13607.
42. Jiang W., Wang X., Zeng B., Liu L., Tardivel A., Wei H., Han J., MacDonald H.R., Tschopp J., Tian Z., et al. Recognition of gut microbiota by NOD2 is essential for the homeostasis of intestinal intraepithelial lymphocytes. J Exp Med 2013, 210:2465-2476.
43. Lee J., Mo J.H., Katakura K., Alkalay I., Rucker A.N., Liu Y.T., Lee H.K., Shen C., Cojocaru G., Shenouda S., et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 2006, 8:1327-1336.
44. Dasgupta S., Erturk-Hasdemir D., Ochoa-Reparaz J., Reinecker H.C., Kasper D.L. Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms. Cell Host Microbe 2014, 15:413-423.
45. Claes I.J., Lebeer S., Shen C., Verhoeven T.L., Dilissen E., De Hertogh G., Bullens D.M., Ceuppens J.L., Van Assche G., Vermeire S., et al. Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis. Clin Exp Immunol 2010, 162:306-314.
46. Claes I.J., Segers M.E., Verhoeven T.L., Dusselier M., Sels B.F., De Keersmaecker S.C., Vanderleyden J., Lebeer S. Lipoteichoic acid is an important microbe-associated molecular pattern of Lactobacillus rhamnosus GG. Microb Cell Fact 2012, 11:161.
47. Cullender T.C., Chassaing B., Janzon A., Kumar K., Muller C.E., Werner J.J., Angenent L.T., Bell M.E., Hay A.G., Peterson D.A., et al. Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut. Cell Host Microbe 2013, 14:571-581.
48. Hooper L.V., Gordon J.I. Glycans as legislators of host-microbial interactions: spanning the spectrum from symbiosis to pathogenicity. Glycobiology 2001, 11:1R-10R.
49. Coyne M.J., Chatzidaki-Livanis M., Paoletti L.C., Comstock L.E. Role of glycan synthesis in colonization of the mammalian gut by the bacterial symbiont Bacteroides fragilis. Proc Natl Acad Sci U S A 2008, 105:13099-13104.
50. Liu C.H., Lee S.M., Vanlare J.M., Kasper D.L., Mazmanian S.K. Regulation of surface architecture by symbiotic bacteria mediates host colonization. Proc Natl Acad Sci U S A 2008, 105:3951-3956.
51. Lebeer S., Claes I.J., Verhoeven T.L., Vanderleyden J., De Keersmaecker S.C. Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestine. Microb Biotechnol 2011, 4:368-374.
52. Lebeer S., Claes I., Tytgat H.L., Verhoeven T.L., Marien E., von Ossowski I., Reunanen J., Palva A., Vos W.M., Keersmaecker S.C., et al. Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl Environ Microbiol 2012, 78:185-193.
53. Kankainen M., Paulin L., Tynkkynen S., von Ossowski I., Reunanen J., Partanen P., Satokari R., Vesterlund S., Hendrickx A.P., Lebeer S., et al. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proc Natl Acad Sci U S A 2009, 106:17193-17198.
54. Tripathi P., Beaussart A., Alsteens D., Dupres V., Claes I., von Ossowski I., de Vos W.M., Palva A., Lebeer S., Vanderleyden J., et al. Adhesion and nanomechanics of pili from the probiotic Lactobacillus rhamnosus GG. ACS Nano 2013, 7:3685-3697.
55. Nickerson K.P., McDonald C. Crohn's disease-associated adherent-invasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin. PLoS ONE 2012, 7:e52132.
56. Basset A., Zhang F., Benes C., Sayeed S., Herd M., Thompson C., Golenbock D.T., Camilli A., Malley R. Toll-like receptor (TLR) 2 mediates inflammatory responses to oligomerized RrgA pneumococcal pilus type 1 protein. J Biol Chem 2013, 288:2665-2675.
57. Lebeer S., Claes I.J., Vanderleyden J. Anti-inflammatory potential of probiotics: lipoteichoic acid makes a difference. Trends Microbiol 2012, 20:5-10.
58. Netea M.G., Wijmenga C., O'Neill L.A. Genetic variation in Toll-like receptors and disease susceptibility. Nat Immunol 2012, 13:535-542.
59. Morgan A.R., Han D.Y., Wickens K., Barthow C., Mitchell E.A., Stanley T.V., Dekker J., Crane J., Ferguson L.R. Differential modification of genetic susceptibility to childhood eczema by two probiotics. Clin Exp Allergy 2014, 44:1255-1265.
60. Takahashi K., Sugi Y., Nakano K., Tsuda M., Kurihara K., Hosono A., Kaminogawa S. Epigenetic control of the host gene by commensal bacteria in large intestinal epithelial cells. J Biol Chem 2011, 286:35755-35762.
61. Bendiks M., Kopp M.V. The relationship between advances in understanding the microbiome and the maturing hygiene hypothesis. Curr Allergy Asthma Rep 2013, 13:487-494.